Nastoupil, Loretta J.
Article History
Accepted: 3 February 2021
First Online: 2 April 2021
Declarations
:
: LJN has received honorarium from the following: Bayer, Celgene, Gamida Cell, Genentech, Gilead/KITE, Janssen, Novartis, TG Therapeutics and research funding from the following: Celgene, Genentech, Janssen, Karus Therapeutics, Lam Therapeutics, Merck, Novartis, TG Therapeutics.
: This article does not contain any studies with human or animal subjects performed by any of the authors.